banner HPMU
TRA CỨU
TÀI LIỆU IN
Skip Navigation Links.
Tài liệu số
Skip Navigation Links.
Thư mục - Vốn tư liệu
The Status of Clinical Trials in Vietnam from 2010 to 2024 An Assessment Using Data from ClinicalTrials.gov

The Status of Clinical Trials in Vietnam from 2010 to 2024 An Assessment Using Data from ClinicalTrials.gov : Khóa luận tốt nghiệp Dược sĩ đại học

 Đỗ Thùy Linh
 HP., 2025
 HP. : 84tr. ; 27cm Tiếng Việt
Dược họcDược lâm sàng
Mô tả biểu ghi
ID:23504
Kí hiệu phân loại B13
Tác giả CN Đỗ Thùy Linh
Nhan đề The Status of Clinical Trials in Vietnam from 2010 to 2024: An Assessment Using Data from ClinicalTrials.gov : Khóa luận tốt nghiệp Dược sĩ đại học / Đỗ Thùy Linh
Thông tin xuất bản HP. :HP.,2025
Mô tả vật lý 84tr. ;27cm
Tóm tắt The number of study records increased over time, with a sharp rise during the COVID-19 pandemic. Domestic sponsors eventually outnumbered international ones. Most studies were interventional, but later-phase trials declined. Although completion rates were relatively high, they dropped significantly (by ~51%). Most studies were completed within 1–3 years, yet over 80% have not published results. Infectious diseases were the most common focus but declined, while neoplasms, circulatory, and mental disorders rose. Drugs dominated, especially synthetic drugs and vaccines. Surgical procedures were the main focus of procedural trials. Nearly half of the studies involved both adults and older adults; studies solely on older adults were rare
Thuật ngữ chủ đề Dược học
Từ khóa tự do Dược học; Dược lâm sàng
Tác giả(bs) CN Nguyễn Thị Thu Phương - hd.
Địa chỉ 100Phòng tra cứu(1): PTC03611
MARC
Hiển thị đầy đủ trường & trường con
TagGiá trị
00000000nam#s2200000ua#4500
00123504
0027
004ILIB-26357
005202507281007
008250728s2025 ||||||viesd
0091 0
039[ ] |a 202507281059 |b ILIB |y 202507281059 |z ILIB
041[ ] |a vie
084[ ] |a B13
100[ ] |a Đỗ Thùy Linh
245[ ] |a The Status of Clinical Trials in Vietnam from 2010 to 2024: An Assessment Using Data from ClinicalTrials.gov : |b Khóa luận tốt nghiệp Dược sĩ đại học / |c Đỗ Thùy Linh
260[ ] |a HP. : |b HP., |c 2025
300[ ] |a 84tr. ; |c 27cm |e File
520[ ] |a The number of study records increased over time, with a sharp rise during the COVID-19 pandemic. Domestic sponsors eventually outnumbered international ones. Most studies were interventional, but later-phase trials declined. Although completion rates were relatively high, they dropped significantly (by ~51%). Most studies were completed within 1–3 years, yet over 80% have not published results. Infectious diseases were the most common focus but declined, while neoplasms, circulatory, and mental disorders rose. Drugs dominated, especially synthetic drugs and vaccines. Surgical procedures were the main focus of procedural trials. Nearly half of the studies involved both adults and older adults; studies solely on older adults were rare
650[ ] |a Dược học
653[ ] |a Dược học
653[ ] |a Dược lâm sàng
700[ ] |a Nguyễn Thị Thu Phương |e hd.
852[ ] |a 100 |b Phòng tra cứu |j (1): PTC03611
890[ ] |a 1 |b 0 |c 0 |d 0
Dòng Mã vạch Bản sao Nơi lưu Tình trạng Cho phép yêu cầu
1 PTC03611 1 Kho tra cứu
#1 PTC03611
Nơi lưu Kho tra cứu
Tình trạng
Bình luận